23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.
Nebraska Medicine & CancerIQ Boost Lung Cancer Risk Assessments by 6x
What You Should Know: – Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk